NCT03024398招募中不适用
Evaluation of the Fluorescent Green of Indocyanine in the Detection of Sentinel Lymph Node in Endometrial Cancer
University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Detection of sentinel node
研究概览
简要总结
Selective lymphadenectomy Sentinel (LSS). This technique is already well established in breast cancer and melanoma and more recently in vulvar and cervical cancer.
Compared to lymphadenectomy, it has several theoretical advantages:
- this is a sensitive technique with a detection rate of> 90% and a false negative rate of <5%.
- the anatomopathological techniques used (immunohistochemistry with anti-cytokeratin antibodies, serial sections) are more sensitive than the standard histological analysis of lymphadenectomy, which allows an improvement in the detection of metastases (micro-metastases, isolated tumor cells). In the SENTI-ENDO study, it was possible to detect lymph node metastases in 11% of patients with low-risk endometrial cancer and in 15% of intermediate-risk patients.
- it avoids short-term and long-term operative and post-operative morbidity of lymphadenectomy.
Early studies of LSS in endometrial cancer demonstrated superior efficacy of the colorimetric method coupled with the Technetium 99m isotopic method with an overall detection rate of 78% [95% CI: 73-84]. The fluorescent green of indocyanine appears to give better results with an overall detection rate of 94% and a bilateral detection rate of 80%.
It seemed useful to take stock of this technique using this new dye.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Major patient, without guardianship or curatorship.
- •patient with endometrial cancer confirmed by biopsy.
- •Invasive cancer stage FIGO I at intermediate risk and high risk and II according to the FIGO classification.
- •need for surgical staging.
- •performing an endovaginal ultrasound or a pelvic MRI in preoperative, if contraindication to MRI, performing a CT scan.
- •subject affiliated to a social health insurance scheme.
- •speaking and reading French.
- •subject having dated and signed informed consent.
排除标准
- •pregnancy in progress.
- •FIGO III and IV stage diagnosed preoperatively or intraoperatively.
- •Cure or pre-surgery that may alter the uterine lymphatic drainage (conization, myomectomy).
- •MRI or CT scan of suspected lymph nodes.
结局指标
主要结局
Detection of sentinel node
时间窗: 1 hour after surgery
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial<p>Breast cancer</p>10006295NL-OMON29593St. Antonius Hospital102
招募中
不适用
Selective Sentinella Lymph Node Biopsy With Indocyanine Green in Patients With Breast CancerBreast CancerNCT06378944Omphis Foundation15,000
已完成
2 期
Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast CancerBreast NeoplasmsNCT01856452National Cancer Center, Korea86
Unknown
4 期
Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast CancerBreast NeoplasmsNCT02781259Samsung Medical Center150
Unknown
2 期
A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast CancerBreast CancerNCT02817334National Cancer Center, Korea149
